Quiz: Radionuclide Therapy A multiple-choice quiz consists of: 10 QuestionsQuestions are selected randomly from a collection of 17 questions. More Questions You will get deferent questions every time you take the quiz. Correct AnswersThere could be more than one correct answer, select all that apply.Skip QuestionsYou are allowed to scroll backward and forward before submitting your answers.10 MinutesThe quiz has a time limit. Time's up You can still submit your answers after the allowed period of time has ended . When ready, click Next to start the quiz. Name (Required) Email (Optional) Twitter (Optional) 1. Which of the following time is advised for patients treated with 1-131 to delay conception after treatment? 2 months 6 months 1 month 4 months None 2. A lone “cold” nodule in an otherwise normal thyroid gland warrants: Surgical removal. Fine needle aspiration biopsy. Radiation therapy. Chemotherapy. None 3. An ultimate treatment for patients who are nonresponsive to or cannot tolerate other available therapies for a particular illness and whose prognosis is often poor is called: Standard therapy. Retreatment. Consolidation therapy. Salvage therapy. None 4. According to the Society of Nuclear Medicine “SNM Procedure Guideline for Therapy of Thyroid Disease with I-131 (Sodium Iodide),” typically administered activity for treatment of presumed thyroid cancer in the neck or mediastinal lymph nodes is in the range: 200–250 mCi. 150–200 mCi. 100–150 mCi. 50–100 mCi. None 5. Samarium-153 (Quadramet) is a therapeutic radiopharmaceutical used to treat: Medullary thyroid carcinoma Pain in bony metastases Polycythemia vera Dyspnea in lung Ca None 6. To reduce radiation exposure to the patient undergoing radioactive iodine (RAI) treatment, all of the following recommendations will be helpful EXCEPT: Patient should use antiperspirant medications Patient should urinate frequently Patient laxatives Patient should be well hydrated None 7. All breastfeeding women undergoing I-131 therapy should be asked to stop breastfeeding and therapy is delayed until lactation ceases. According to the Society of Nuclear Medicine (SNM) procedure guidelines, the patient may resume breastfeeding: After 6 months. After 3 months. With the birth of another child. Never. None 8. Transient increase in tracer uptake in responding metastases in the early months after chemotherapy/hormone therapy for breast and prostate cancer is called: Flare scan. Super phenomenon. Super scan. Flare phenomenon. None 9. The hematologic toxicity of Y-90 Zevalin therapy is common. All of the following can be a sign of hematologic toxicity EXCEPT: Anemia Arrhythmia Bruising Fever None 10. The general pretreatment requirements for adult qualifying for therapy with I-131 metaiodobenzylguanidine (MIBG) include the following EXCEPT: A diagnostic MIBG scan or previous posttreatment I-131 MIBG scan Blocking thyroid uptake of free radioiodine Performing pulmonary function tests Reviewing potential interfering medications None 1 out of 10 Time's upTime is Up! By Nasser AlMutairi|2021-09-20T13:15:38+03:00April 26th, 2021|Radionuclide Therapy| شارك هذه الصفحة FacebookXLinkedInWhatsAppPinterestEmail About the Author: Nasser AlMutairi Senior Nuclear Medicine Specialist at Hafar Al-Batin Central Hospital, Founder of NuclearMed Website. One Comment Muawia Ibrahim Elgak January 10, 2025 at 6:37 pm - Reply Thank you for your questions Leave A Comment Cancel replyComment Notify me of follow-up comments by email. Notify me of new posts by email. Δ
Thank you for your questions